Biosplice Therapeutics is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Biosplice Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Biosplice Therapeutics is a clinical-stage biotechnology company developing therapeutics based on alternative splicing modulation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.